Could the CSL (ASX:CSL) share price get back on track in 2021?

The CSL Limited (ASX: CSL) share price has gone nowhere since March 2020. Citi thinks it could get back on track with the vaccine rollout.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price has underperformed the market since the initial COVID-19 sell-off in March 2020. After such a prolonged period of underperformance, Citi thinks the CSL share price could get back on track. 

Strong earnings but plasma collections weigh on CSL share price 

CSL announced a strong half-year report for the six months ended 31 December with group revenue up 16.9% on the prior corresponding period to US$5,739 million. A strong uplift in margins drove its 45% surge in net profit after tax to US$1,810 million. 

At face value, the company's results appear very strong and above CSL's historic mid-teens growth. However, the company did acknowledge that the COVID-19 pandemic had tempered CSL Behring's performance whilst boosting the performance of Seqirus. 

Plasma collections are an essential raw material used in the production of many of the company's therapies. Plasma collection centres and manufacturing facilities are classified as an essential service and remained operational during the pandemic. Despite being open, the company noted in its half-year results that "our plasma collections have been adversely affected during the pandemic". The company reported that collections volumes in December 2020 were ~80% of December 2019 volumes. 

The company has taken several initiatives to improve plasma collections. This includes enhanced targeted marketing initiatives to increase collections, roll out of COVID-19 vaccine to increase social mobility and targeting an additional 12 new centres to be opened in 1H21. 

Citi sees upside to the CSL share price

Citi believes that the current decline in plasma collections is likely to stabilise after the US's COVID vaccine rollout. 

The US has also experienced a significant decline in new daily COVID cases. Its new daily cases surged from an average of 50,000 cases per day in October 2020 to a peak of more than 300,000 cases in January 2021. As of 8 March, the US reported 98,000 cases with a 7-day average of 64,700. 

Citi left its CSL share price target unchanged at $310 with the assumption that plasma donations are back to normal by July 2020. CSL noted that as plasma volumes recover, the cost per litre of plasma reduces, leading to better margins. 

Should you invest $1,000 in Frontier Digital Ventures Limited right now?

Before you buy Frontier Digital Ventures Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Frontier Digital Ventures Limited wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Person pretends to types on laptop drawn in sand.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy finish to the week for ASX shares this Friday.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A mature age woman with a groovy short haircut and glasses, sits at her computer, pen in hand thinking about information she is seeing on the screen.
Share Market News

ASX shares in April: 8 key takeaways according to Macquarie

Here are eight key takeaways from April, according to a new note from the broker.

Read more »

Woman looking at a phone with stock market bars in the background.
Share Market News

Market outlook: Should I 'sell in May and go away'?

May is the time to sell... If you believe in fairytales.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

5 ASX All Ords stocks rocketing higher this week

Investors sent these five ASX All Ords stocks soaring this week. But why?

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Block, Corporate Travel Management, Judo, and Zip shares are sinking today

These shares are missing out on the good times on Friday. But why?

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why Boss Energy, Capstone, Dimerix, and Platinum shares are storming higher today

These shares are having a good finish to the week. Let's find out why.

Read more »

A shocked man holding some documents in the living room.
Broker Notes

Macquarie's take on Judo Capital shares after suddenly falling 19% yesterday?

Judo Bank was the ASX's top-performing banking stock in 2024.

Read more »